Display options
Cite
Guan YG, Liao JB, Li KY, et al. Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model. Evid Based Complement Alternat Med. 2014;2014:982913doi: 10.1155/2014/982913.
Guan, Y. G., Liao, J. B., Li, K. Y., Li, Y. C., Song, Y., Ling, J., & Su, Z. R. (2014). Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model. Evidence-based complementary and alternative medicine : eCAM, 2014982913. https://doi.org/10.1155/2014/982913
Guan, Yong-Ge, et al. "Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model." Evidence-based complementary and alternative medicine : eCAM vol. 2014 (2014): 982913. doi: https://doi.org/10.1155/2014/982913
Guan YG, Liao JB, Li KY, Li YC, Song Y, Ling J, Su ZR. Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model. Evid Based Complement Alternat Med. 2014;2014:982913. doi: 10.1155/2014/982913. Epub 2014 Nov 10. PMID: 25435895; PMCID: PMC4243767.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2014;2014:982913. doi: 10.1155/2014/982913. Epub 2014 Nov 10.

Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model.

Evidence-based complementary and alternative medicine : eCAM

Yong-Ge Guan, Jin-Bin Liao, Kun-Yin Li, Yu-Cui Li, Yang Song, Jing Ling, Zi-Ren Su

Affiliations

  1. First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
  2. School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China ; Guangdong Second Province Hospital of Traditional Chinese Medicine, Guangzhou 510095, China.
  3. School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  4. School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

PMID: 25435895 PMCID: PMC4243767 DOI: 10.1155/2014/982913

Abstract

Background. Shaoyao-Gancao Decoction (SGD), a well-known traditional Chinese medicine prescription, has been widely used to treat adenomyosis, dysmenorrhea, abdominal pain, and inflammation in Asia. However, the mechanism underlying the effectiveness of SGD in the treatment of adenomyosis still remains elusive. The present study aimed to investigate the bioactivity of SGD and its underlying molecular mechanisms using cultured human adenomyosis-derived cells. Methods. Human adenomyosis-derived cells were treated with SGD and its major constituents (paeoniflorin and liquiritin) in vitro. Effects of SGD, paeoniflorin, and liquiritin on cell proliferation and apoptosis were examined by MTT assay and flow cytometry analyses. The effects of SGD, paeoniflorin, and liquiritin on the production of PGE2 and PGF2α were assayed using ELISA. ER-α and OTR mRNA expression levels were also evaluated by real-time qRT-PCR. Results. SGD, paeoniflorin, and liquiritin inhibited proliferation and induced apoptosis of human adenomyosis-derived cells in a dose-dependent manner. SGD and paeoniflorin significantly reduced the PGE2 and PGF2α production. Furthermore, they remarkably decreased the mRNA levels of ER-α and OTR. Conclusions. The results of this study provide possible mechanisms for the bioactivity of SGD for treating adenomyosis and contribute to the ethnopharmacological knowledge about this prescription.

References

  1. Mol Cell Endocrinol. 2008 Mar 26;285(1-2):51-61 - PubMed
  2. Hum Reprod. 2013 May;28(5):1324-38 - PubMed
  3. J Vasc Interv Radiol. 1999 Oct;10(9):1159-65 - PubMed
  4. J Pharm Biomed Anal. 2008 Dec 15;48(5):1462-6 - PubMed
  5. Fertil Steril. 2013 Jan;99(1):231-40 - PubMed
  6. J Ethnopharmacol. 2012 Jun 26;142(1):188-93 - PubMed
  7. J Obstet Gynaecol Res. 2014 Feb;40(2):485-94 - PubMed
  8. Hum Reprod. 2001 Jan;16(1):51-55 - PubMed
  9. Hum Reprod. 2007 Apr;22(4):945-52 - PubMed
  10. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:76-87 - PubMed
  11. Fertil Steril. 2008 Jan;89(1):246-50 - PubMed
  12. J Ethnopharmacol. 2013 Feb 13;145(3):767-75 - PubMed
  13. J Pharmacobiodyn. 1984 Jul;7(7):427-35 - PubMed
  14. Annu Rev Pharmacol Toxicol. 1998;38:97-120 - PubMed
  15. Toxicol Lett. 2009 Sep 10;189(2):166-75 - PubMed
  16. Reproduction. 2003 Nov;126(5):559-67 - PubMed
  17. J Ethnopharmacol. 2006 May 24;105(3):409-14 - PubMed
  18. Planta Med. 2012 Feb;78(3):237-43 - PubMed
  19. Nihon Sanka Fujinka Gakkai Zasshi. 1996 May;48(5):321-7 - PubMed
  20. Mol Cell. 2007 Jun 8;26(5):745-52 - PubMed
  21. Am J Chin Med. 1993;21(3-4):263-8 - PubMed
  22. J Pharmacobiodyn. 1982 Nov;5(11):921-9 - PubMed
  23. Fertil Steril. 2007 Jan;87(1):33-8 - PubMed
  24. J Ethnopharmacol. 2013 Sep 16;149(2):443-52 - PubMed
  25. Jpn J Pharmacol. 1984 Nov;36(3):275-82 - PubMed
  26. BMC Cancer. 2008 Nov 06;8:322 - PubMed
  27. Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):511-21 - PubMed
  28. Prostaglandins Leukot Essent Fatty Acids. 1992 Jun;46(2):133-7 - PubMed
  29. Am J Obstet Gynecol. 2010 Apr;202(4):346.e1-8 - PubMed
  30. Arch Pharm Res. 2011 Feb;34(2):203-10 - PubMed
  31. Cytotechnology. 2009 Jul;60(1-3):125-32 - PubMed
  32. Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):493-502 - PubMed
  33. Obstet Gynecol. 1991 Sep;78(3 Pt 2):538-9 - PubMed
  34. Obstet Gynecol Clin North Am. 1989 Mar;16(1):221-35 - PubMed
  35. Jpn J Pharmacol. 1986 Jun;41(2):263-5 - PubMed
  36. Int J Mol Med. 2005 Aug;16(2):233-6 - PubMed
  37. Planta Med. 1997 Aug;63(4):323-5 - PubMed
  38. Br J Obstet Gynaecol. 1983 Dec;90(12):1135-40 - PubMed
  39. Pharmacol Biochem Behav. 1993 Jul;45(3):719-23 - PubMed
  40. J Sep Sci. 2013 Apr;36(7):1238-46 - PubMed
  41. Chin J Nat Med. 2013 Nov;11(6):596-607 - PubMed
  42. Fertil Steril. 2010 Nov;94(6):1972-9, 1979.e1-4 - PubMed
  43. J Clin Endocrinol Metab. 2009 Feb;94(2):615-22 - PubMed
  44. J Nutr. 2004 Jun;134(6):1529-35 - PubMed
  45. J Clin Endocrinol Metab. 1996 Nov;81(11):4144-7 - PubMed
  46. Dev Biol. 2003 Jun 15;258(2):264-76 - PubMed
  47. Reprod Sci. 2011 Oct;18(10):1025-37 - PubMed
  48. Inflamm Res. 2007 May;56(5):182-8 - PubMed
  49. Molecules. 2012 Dec 13;17 (12 ):14908-17 - PubMed
  50. Toxicol Pathol. 2007 Jun;35(4):495-516 - PubMed
  51. Nat Rev Cancer. 2004 Aug;4(8):592-603 - PubMed
  52. Clin Exp Obstet Gynecol. 2003;30(2-3):95-8 - PubMed
  53. Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):204-9 - PubMed
  54. Hum Reprod Update. 1998 Jul-Aug;4(4):312-22 - PubMed
  55. Menopause. 2001 Sep-Oct;8(5):368-71 - PubMed
  56. Am J Obstet Gynecol. 2001 Dec;185(6):1374-80 - PubMed
  57. Obstet Gynecol Surv. 1999 Dec;54(12):745-53 - PubMed
  58. J Altern Complement Med. 2006 Jul-Aug;12(6):535-41 - PubMed
  59. J Med. 1995;26(3-4):163-74 - PubMed

Publication Types